Hutch News
Results per Page:
Dr. Martin 'Mac' Cheever, cancer immunotherapy expert, receives distinguished service award
Honor recognizes his work establishing Cancer Immunotherapy Trials Network
High impact of positive and negative clinical trial results
From the Unger Group, Division of Public Health Sciences
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Cancer patients find clinical trials, hope and help
#NWMetsConf connects metastatic breast cancer patients with trials, treatments, tools and each other
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Increased racial and ethnic minority participation in HIV vaccine trials
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Research shows structural barriers are the biggest reason for low participation in clinical trials
Findings in Journal of the National Cancer Institute shows patients don’t have enough opportunities for participation
Structural and clinical barriers keep 3 of 4 cancer patients from participating in trials
‘Patients are willing to participate in trials if they’re offered one’
Comorbidities impede clinical trial participation
From the Unger Group, Public Health Sciences Division
How to boost cancer clinical trial participation
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
UCI-Fred Hutch collaboration turns 10
In Uganda, innovation and persistence allow a 'sustainable cancer program' to take root
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
What's new in prostate cancer: 5 takeaways
‘Many reasons for optimism’ says expert at annual community symposium
Early phase clinical trial shows promise for advanced head and neck cancer
Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
With approval of new CMV drug for transplant patients, a legacy continues
Tissue samples from a clinical trial conducted decades ago yield new insights and treatments
Meet Global Oncology's deputy program head
Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health
How new drugs become available to more patients
Filling in the unknowns on the balance between risk and benefit